# Commission Regulation (EU) No 618/2012 of 10 July 2012 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (Text with EEA relevance), Annex II

Extent: E+W+S+N.I.

Index No
International Chemical Identification
EC No
CAS No
Classification
Labelling
Specific Conc. Limits, M-factors
Notes
Hazard Class and Category Code(s)
Hazard Statement Code(s)
Pictogram, Signal Word Code(s)
Hazard statement Code(s)
Suppl. Hazard statement Code(s)
‘015-199-00-X
tris[2-chloro-1-chloromethyl)ethyl] phosphate
237-159-2
13674-87-8
Carc. 2
H351
GSH08
Wng
H351
015-200-00-3
indium phosphide
244-959-5
22398-80-7
Carc. 1B
Repr. 2
STOT RE 1
H350
H361f
H372 (lungs)
GHS08
Dgr
H350
H361f
H372 (lungs)
STOT RE 1;
H372: C ≥0,1 %
Carc 1B;
H350: C ≥0,01 %
STOT RE 2;
H373: 0,01 % ≤ C < 0,1 %
015-201-00-9
trixylyl phosphate
246-677-8
25155-23-1
Repr. 1B
H360F
GHS08
Dgr
H360F
015-202-00-4
tris(nonylphenyl) phosphite
247-759-6
26523-78-4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
015-203-00-X
diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide
278-355-8
75980-60-8
Repr. 2
H361f (causing atrophy of the testes)
GHS08
Wng
H361f (causing atrophy of the testes)
602-109-00-4
Hexabromocyclododecane [1]
247-148-4 [1]
25637-99-4[1]
Repr. 2
Lact.
H361
H362
GHS08
Wng
H361
H362
1,2,5,6,9,10-hexabromocyclododecane [2]
221-695-9[2]
3194-55-6[2]
606-143-00-0
abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]
_ [1]
71751-41-2 [1]
Repr. 2
Acute Tox. 2
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H361d
H300
H330
H372 (nervous system)
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d
H300
H330
H372 (nervous system)
H410
STOT RE 1;
H372: C ≥ 5 %
STOT RE 2;
H373: 0,5 % ≤C<5 %
M = 10 000
avermectin B1a (purity ≥80 %); [2]
265-610-3 [2]
65195-55-3 [2]
606-144-00-6
acequinocyl (ISO);
3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate
—
57960-19-7
Skin Sens. 1
STOT SE 1
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H317
H370 (lung)
(inhalation)
H373 (blood system)
H400
H410
GHS07
GHS08
GHS09
Dgr
H317
H370 (lung)
(inhalation)
H373 (blood system)
H410
M = 1 000
607-698-00-1
4-tert-butylbenzoic acid
202-696-3
98-73-7
Repr. 1B
STOT RE 1
Acute Tox. 4
H360F
H372
H302
GHS07
GHS08
Dgr
H360F
H372
H302
612-281-00-2
leucomalachite green;
N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline
204-961-9
129-73-7
Carc. 2
Muta. 2
H351
H341
GHS08
Wng
H351
H341
616-205-00-9
Metazachlor (ISO);
2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide
266-583-0
67129-08-2
Skin Sens. 1B
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H317
H351
H400
H410
GHS07
GHS08
GHS09
Wng
H317
H351
H410
M = 100
M = 100’

---
Source: https://www.legislation.gov.uk/eur/2012/618/annex/II (the official version)
Page: https://openlegislation.uk/eu-regulation-2012-618/annex-II
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.